Alpha Tau Medical Ltd. (DRTS): Aggregate Business Value

The market price action visualized on the GURU.Markets platform for analytical convenience shows that the Enterprise Value of Alpha Tau Medical Ltd. (DRTS) is 1144.96. Business revenues will be based on the sale of DaRT devices for local tumor irradiation. Meanwhile, automated laboratories equipped with robots accelerate the search for new formulas through continuous screening. The strategy relies on the implementation of alpha-therapy methods for precise radiation targeting of cancer cells.

The integration of proprietary software and applicators from Alpha Tau Medical Ltd. (DRTS) creates a high level of clinic dependency on the vendor's technologies, driving long-term business value. An analysis of the company's total market valuation allows for the determination of the asset's real price through the sum of market capitalization and net debt, which is critical for assessing the fundamental value of this high-tech medical enterprise.